QIA.F QIAGEN NV

Healthcare Biotechnology Frankfurt Exchange
45.34 EUR
Close of Nov 12, 2026
27.62 48.37
Market cap
EUR 9.36B
P/E
28.5x
P/B
2.99x
ROE
10.6%
Dividend yield
0.69%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is QIA.F undervalued?

Graham number
Price45.34
Graham value23.31
Premium94.6%

QIA.F trades 94.6% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

QIAGEN NV fundamental analysis

No fundamental analysis for QIAGEN NV yet.

QIAGEN NV stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About QIAGEN NV

Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components fo…

Full company profile